. . . . . "vedeck\u00FD \u010Dl\u00E1nok (publikovan\u00FD 2001/11/01)"@sk . . . . . . . . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@ast . . . . . "R Mazitschek" . "2001 \u0569\u057E\u0561\u056F\u0561\u0576\u056B \u0576\u0578\u0575\u0565\u0574\u0562\u0565\u0580\u056B\u0576 \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u057E\u0561\u056E \u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0570\u0578\u0564\u057E\u0561\u056E"@hy . . . "\u0645\u0642\u0627\u0644\u0629 \u0639\u0644\u0645\u064A\u0629 (\u0646\u0634\u0631\u062A \u0641\u064A \u0646\u0648\u0641\u0645\u0628\u0631 2001)"@ar . . . . . "A Giannis" . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@ast . . . "2001-11-01T00:00:00Z"^^ . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@nl . . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@en . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u043B\u0438\u0441\u0442\u043E\u043F\u0430\u0434\u0456 2001"@uk . "im November 2001 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . . . . . "3204359" . "wetenschappelijk artikel (gepubliceerd op 2001/11/01)"@nl . "229507071" . "11683876" . . . "21" . . . . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@en . . . "10.1046/J.1432-1033.2001.02476.X" . . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@nl . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en 2001"@ast . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@en . . . . . "5530-5540" . . . . . . . "A Steffen" . . . . . . . . . . . . . "J P Sleeman" . . . . . . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@en . . . . . . . . "v\u011Bdeck\u00FD \u010Dl\u00E1nek publikovan\u00FD v roce 2001"@cs . . . . "J Waltenberger" . . . . "2001 \u0569\u0578\u0582\u0561\u056F\u0561\u0576\u056B \u0546\u0578\u0575\u0565\u0574\u0562\u0565\u0580\u056B\u0576 \u0570\u0580\u0561\u057F\u0561\u0580\u0561\u056F\u0578\u0582\u0561\u056E \u0563\u056B\u057F\u0561\u056F\u0561\u0576 \u0575\u0585\u0564\u0578\u0582\u0561\u056E"@hyw . . . . "scientific journal article"@en . . . . . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@ast . . . . . "268" . "Characterization of indolinones which preferentially inhibit VEGF-C- and VEGF-D-induced activation of VEGFR-3 rather than VEGFR-2"@nl .